 | • レポートコード：MRC2-11QY12331 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は不適切管理2型糖尿病治療のグローバル市場について調査・分析したレポートです。種類別（成人、子供）市場規模、用途別（病院、研究）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別不適切管理2型糖尿病治療の競争状況、市場シェア ・世界の不適切管理2型糖尿病治療市場：種類別市場規模 2015年-2020年（成人、子供） ・世界の不適切管理2型糖尿病治療市場：種類別市場規模予測 2021年-2026年（成人、子供） ・世界の不適切管理2型糖尿病治療市場：用途別市場規模 2015年-2020年（病院、研究） ・世界の不適切管理2型糖尿病治療市場：用途別市場規模予測 2021年-2026年（病院、研究） ・北米の不適切管理2型糖尿病治療市場分析：米国、カナダ ・ヨーロッパの不適切管理2型糖尿病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの不適切管理2型糖尿病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の不適切管理2型糖尿病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの不適切管理2型糖尿病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi S.A.、Boehringer Ingelheim GmbH、Eli Lilly and Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetes is a serious complex condition which can affect the entire body. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Insulin secreted by pancreas in hormone made by beta cell which is responsible for the conversion of glucose from food to energy. There are different types of diabetes, all type diabetes serious and complex body condition. The three main types of diabetes are type 1, type 2 and gestational diabetes.Type 2 is prolonged condition of body which inadequate production of insulin by pancreas to convert the glucose from food energy. Type 2 diabetes is strongly associated with genetic and family related risk factors. In general, type 2 diabetes develop occur in adults after the age of 45 but nowadays the prevalence of children and young adults suffering from diabetes are is increasing.
Market Analysis and Insights: Global Inadequately Controlled Type-II Diabetes Treatment Market
The global Inadequately Controlled Type-II Diabetes Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Inadequately Controlled Type-II Diabetes Treatment Scope and Market Size
Inadequately Controlled Type-II Diabetes Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inadequately Controlled Type-II Diabetes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi S.A.
Boehringer Ingelheim GmbH
Eli Lilly and Company
…
Market segment by Type, the product can be split into
Adult
Child
Market segment by Application, split into
Hospital
Research
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inadequately Controlled Type-II Diabetes Treatment Revenue
1.4 Market by Type
1.4.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Adult
1.4.3 Child
1.5 Market by Application
1.5.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Perspective (2015-2026)
2.2 Global Inadequately Controlled Type-II Diabetes Treatment Growth Trends by Regions
2.2.1 Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Inadequately Controlled Type-II Diabetes Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Inadequately Controlled Type-II Diabetes Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Inadequately Controlled Type-II Diabetes Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Inadequately Controlled Type-II Diabetes Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Inadequately Controlled Type-II Diabetes Treatment Players by Market Size
3.1.1 Global Top Inadequately Controlled Type-II Diabetes Treatment Players by Revenue (2015-2020)
3.1.2 Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Inadequately Controlled Type-II Diabetes Treatment Market Concentration Ratio
3.2.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Inadequately Controlled Type-II Diabetes Treatment Revenue in 2019
3.3 Inadequately Controlled Type-II Diabetes Treatment Key Players Head office and Area Served
3.4 Key Players Inadequately Controlled Type-II Diabetes Treatment Product Solution and Service
3.5 Date of Enter into Inadequately Controlled Type-II Diabetes Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Inadequately Controlled Type-II Diabetes Treatment Historic Market Size by Type (2015-2020)
4.2 Global Inadequately Controlled Type-II Diabetes Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
5.2 Global Inadequately Controlled Type-II Diabetes Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Inadequately Controlled Type-II Diabetes Treatment Market Size (2015-2020)
6.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in North America (2019-2020)
6.3 North America Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020)
6.4 North America Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Inadequately Controlled Type-II Diabetes Treatment Market Size (2015-2020)
7.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Europe (2019-2020)
7.3 Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020)
7.4 Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
8 China
8.1 China Inadequately Controlled Type-II Diabetes Treatment Market Size (2015-2020)
8.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in China (2019-2020)
8.3 China Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020)
8.4 China Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Inadequately Controlled Type-II Diabetes Treatment Market Size (2015-2020)
9.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Japan (2019-2020)
9.3 Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020)
9.4 Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size (2015-2020)
10.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
11 India
11.1 India Inadequately Controlled Type-II Diabetes Treatment Market Size (2015-2020)
11.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in India (2019-2020)
11.3 India Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020)
11.4 India Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size (2015-2020)
12.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020)
12.4 Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Details
13.1.2 Sanofi S.A. Business Overview
13.1.3 Sanofi S.A. Inadequately Controlled Type-II Diabetes Treatment Introduction
13.1.4 Sanofi S.A. Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2015-2020))
13.1.5 Sanofi S.A. Recent Development
13.2 Boehringer Ingelheim GmbH
13.2.1 Boehringer Ingelheim GmbH Company Details
13.2.2 Boehringer Ingelheim GmbH Business Overview
13.2.3 Boehringer Ingelheim GmbH Inadequately Controlled Type-II Diabetes Treatment Introduction
13.2.4 Boehringer Ingelheim GmbH Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2015-2020)
13.2.5 Boehringer Ingelheim GmbH Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview
13.3.3 Eli Lilly and Company Inadequately Controlled Type-II Diabetes Treatment Introduction
13.3.4 Eli Lilly and Company Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Inadequately Controlled Type-II Diabetes Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Inadequately Controlled Type-II Diabetes Treatment Revenue
Table 3. Ranking of Global Top Inadequately Controlled Type-II Diabetes Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Inadequately Controlled Type-II Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Adult
Table 6. Key Players of Child
Table 7. Global Inadequately Controlled Type-II Diabetes Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions (2015-2020)
Table 11. Global Inadequately Controlled Type-II Diabetes Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Inadequately Controlled Type-II Diabetes Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Inadequately Controlled Type-II Diabetes Treatment Players
Table 18. Global Inadequately Controlled Type-II Diabetes Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Players (2015-2020)
Table 20. Global Top Inadequately Controlled Type-II Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inadequately Controlled Type-II Diabetes Treatment as of 2019)
Table 21. Global Inadequately Controlled Type-II Diabetes Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Inadequately Controlled Type-II Diabetes Treatment Product Solution and Service
Table 24. Date of Enter into Inadequately Controlled Type-II Diabetes Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Inadequately Controlled Type-II Diabetes Treatment Market Size Share by Type (2015-2020)
Table 28. Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Inadequately Controlled Type-II Diabetes Treatment Market Size Share by Application (2015-2020)
Table 30. Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Inadequately Controlled Type-II Diabetes Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2019-2020)
Table 34. North America Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2015-2020)
Table 36. North America Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2019-2020)
Table 40. Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2015-2020)
Table 42. Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2019-2020)
Table 46. China Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2015-2020)
Table 48. China Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2019-2020)
Table 52. Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2015-2020)
Table 54. Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2019-2020)
Table 58. Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2019-2020)
Table 64. India Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2015-2020)
Table 66. India Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2019-2020)
Table 70. Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2015-2020)
Table 74. Sanofi S.A. Company Details
Table 75. Sanofi S.A. Business Overview
Table 76. Sanofi S.A. Product
Table 77. Sanofi S.A. Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2015-2020) (Million US$)
Table 78. Sanofi S.A. Recent Development
Table 79. Boehringer Ingelheim GmbH Company Details
Table 80. Boehringer Ingelheim GmbH Business Overview
Table 81. Boehringer Ingelheim GmbH Product
Table 82. Boehringer Ingelheim GmbH Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2015-2020) (Million US$)
Table 83. Boehringer Ingelheim GmbH Recent Development
Table 84. Eli Lilly and Company Company Details
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Product
Table 87. Eli Lilly and Company Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2015-2020) (Million US$)
Table 88. Eli Lilly and Company Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Type: 2020 VS 2026
Figure 2. Adult Features
Figure 3. Child Features
Figure 4. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Research Case Studies
Figure 7. Inadequately Controlled Type-II Diabetes Treatment Report Years Considered
Figure 8. Global Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Players in 2019
Figure 13. Global Top Inadequately Controlled Type-II Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inadequately Controlled Type-II Diabetes Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Inadequately Controlled Type-II Diabetes Treatment Revenue in 2019
Figure 15. North America Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
糖尿病治療の世界市場（～2026年） Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved people's living habits, disease control effect, is becoming m…- 徐放性ドラッグデリバリーの世界市場（～2026年） Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time. Controlled drug delivery systems can include the maintenance of druglevels within a desired range, the need for fewer administrations, optimal use of the drug…
- ライフサイエンス規制薬物注文システムの世界市場（～2026年） A Controlled Substance Ordering System (CSOS) is a form of digital identity issued by the Drug Enforcement Administration’s CSOS Certification Authority, allowing electronic ordering of controlled substances under Schedule I, II, III, and IV. The CSOS certificate is the digital equivalent of identit…
- 徐放性経口用ドラッグデリバリー技術の世界市場（～2026年） The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes.…
- 温度管理包装容器の世界市場（～2026年） The temperature control material is specially designed to meet the temperature requirements of the product. These materials are widely used in food and beverage, medical care and so on. Market Analysis and Insights: Global Temperature Controlled Packaging Containers Market The global Temperature Con…